Abstract
Pre-eclampsia affects approximately 5% of pregnancies and remains a leading cause of maternal and neonatal mortality and morbidity in the United States and the world1,2. The clinical hallmarks of this maternal disorder include hypertension, proteinuria, endothelial dysfunction and placental defects. Advanced-stage clinical symptoms include cerebral hemorrhage, renal failure and the HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome. An effective treatment of pre-eclampsia is unavailable owing to the poor understanding of the pathogenesis of the disease. Numerous recent studies3,4,5 have shown that women with pre-eclampsia possess autoantibodies, termed AT1-AAs, that bind and activate the angiotensin II receptor type 1a (AT1 receptor). We show here that key features of pre-eclampsia, including hypertension, proteinuria, glomerular endotheliosis (a classical renal lesion of pre-eclampsia), placental abnormalities and small fetus size appeared in pregnant mice after injection with either total IgG or affinity-purified AT1-AAs from women with pre-eclampsia. These features were prevented by co-injection with losartan, an AT1 receptor antagonist, or by an antibody neutralizing seven–amino-acid epitope peptide. Thus, our studies indicate that pre-eclampsia may be a pregnancy-induced autoimmune disease in which key features of the disease result from autoantibody-induced angiotensin receptor activation. This hypothesis has obvious implications regarding pre-eclampsia screening, diagnosis and therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Roberts, J.M. & Cooper, D.W. Pathogenesis and genetics of pre-eclampsia. Lancet 357, 53–56 (2001).
Redman, C.W. & Sargent, I.L. Latest advances in understanding pre-eclampsia. Science 308, 1592–1594 (2005).
Luft, F.C. The pre-eclampsia enigma and the renin-angiotensin system. J. Mol. Med. 78, 63–65 (2000).
Xia, Y., Zhou, C.C., Ramin, S.M. & Kellems, R.E. Angiotensin receptors, autoimmunity, and pre-eclampsia. J. Immunol. 179, 3391–3395 (2007).
Xia, Y., Ramin, S.M. & Kellems, R.E. Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of pre-eclampsia. Hypertension 50, 269–275 (2007).
Granger, J.P., Alexander, B.T., Llinas, M.T., Bennett, W.A. & Khalil, R.A. Pathophysiology of pre-eclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 9, 147–160 (2002).
Roberts, L. et al. Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension 47, 615–618 (2006).
Levine, R.J. et al. Soluble endoglin and other circulating antiangiogenic factors in pre-eclampsia. N. Engl. J. Med. 355, 992–1005 (2006).
Levine, R.J. et al. Circulating angiogenic factors and the risk of pre-eclampsia. N. Engl. J. Med. 350, 672–683 (2004).
Levine, R.J. et al. Urinary placental growth factor and risk of pre-eclampsia. J. Am. Med. Assoc. 293, 77–85 (2005).
Borzychowski, A.M., Sargent, I.L. & Redman, C.W. Inflammation and pre-eclampsia. Semin. Fetal Neonatal Med. 11, 309–316 (2006).
Dechend, R. et al. Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of pre-eclampsia. Hypertension 45, 742–746 (2005).
de Jong, C.L., Dekker, G.A. & Sibai, B.M. The renin-angiotensin-aldosterone system in pre-eclampsia. A review. Clin. Perinatol. 18, 683–711 (1991).
Zhou, C.C. et al. Angiotensin II induces soluble fms-like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy. Circ. Res. 100, 88–95 (2007).
Herse, F. et al. Dysregulation of the circulating and tissue-based renin-angiotensin system in pre-eclampsia. Hypertension 49, 604–611 (2007).
Wallukat, G. et al. Patients with pre-eclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J. Clin. Invest. 103, 945–952 (1999).
Xia, Y., Wen, H.Y., Bobst, S., Day, M.C. & Kellems, R.E. Maternal autoantibodies from pre-eclampsia patients activate angiotensin receptors on human trophoblast cells. J. Soc. Gyenocol. Investig. 10, 82–93 (2003).
Bobst, S.M., Day, M.C., Gilstrap, L.C., III, Xia, Y. & Kellems, R.E. Maternal autoantibodies from pre-eclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion. Am. J. Hypertens. 18, 330–336 (2005).
Dechend, R. et al. AT1 receptor agonistic antibodies from pre-eclamptic patients cause vascular cells to express tissue factor. Circulation [see comment] 101, 2382–2387 (2000).
Dechend, R. et al. AT1 receptor agonistic antibodies from pre-eclamptic patients stimulate NADPH oxidase. Circulation 107, 1632–1639 (2003).
Thway, T.M. et al. Antibodies from pre-eclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation. Circulation 110, 1612–1619 (2004).
Zhou, C.C. et al. Autoantibody from women with pre-eclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T cells signaling. Hypertension 51, 1010–1019 (2008).
Eskenazi, B., Fenster, L., Sidney, S. & Elkin, E.P. Fetal growth retardation in infants of multiparous and nulliparous women with pre-eclampsia. Am. J. Obstet. Gynecol. 169, 1112–1118 (1993).
Maynard, S.E. et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in pre-eclampsia. J. Clin. Invest. 111, 649–658 (2003).
Venkatesha, S. et al. Soluble endoglin contributes to the pathogenesis of pre-eclampsia. Nat. Med. 12, 642–649 (2006).
Roberts, J.M. & Lain, K.Y. Recent insights into the pathogenesis of pre-eclampsia. Placenta 23, 359–372 (2002).
Alexander, B.T. et al. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 37, 1191–1195 (2001).
Alexander, B.T. et al. Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension 37, 485–489 (2001).
Barron, L.A., Giardina, J.B., Granger, J.P. & Khalil, R.A. High-salt diet enhances vascular reactivity in pregnant rats with normal and reduced uterine perfusion pressure. Hypertension 38, 730–735 (2001).
Granger, J.P., Alexander, B.T., Llinas, M.T., Bennett, W.A. & Khalil, R.A. Pathophysiology of hypertension during pre-eclampsia linking placental ischemia with endothelial dysfunction. Hypertension 38, 718–722 (2001).
Llinas M., Wallukat G, D.R., Mueller DN, Luft FC, Alexander BT, Lamarca BB & Granger JP. Agonistic autoantibodies to the AT1 receptor in a rat model of pre-eclampsia induced by chronic reductions in uterine perfusion pressure (RUPP). Hypertension 46, 883 (abstract LB48) (2005).
LaMarca, B.B., Cockrell, K., Sullivan, E., Bennett, W. & Granger, J.P. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension 46, 82–86 (2005).
Gilbert, J.S., Babcock, S.A. & Granger, J.P. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 50, 1142–1147 (2007).
Dechend, R., Llinas, M., Caluwaerts, S., Herse, F., Lamarca, B., Mueller, D.N., Luft, FC, Pijnenborg, R., Wallukat, G. & Granger, J.P. Agonistic autoantibodies to the AT1 receptor in rat models of pre-eclampsia: induced by chronic reduction in uterine perfusion pressure (RUPP) and low dose TNF-α infusion. Hypertens. Pregnancy 25, abstract 70 (2006).
LaMarca, B.B., Bennett, W.A., Alexander, B.T., Cockrell, K. & Granger, J.P. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-α. Hypertension 46, 1022–1025 (2005).
Campbell, D.M., MacGillivray, I. & Carr-Hill, R. Pre-eclampsia in second pregnancy. Br. J. Obstet. Gynaecol. 92, 131–140 (1985).
Pijnenborg, R., Vercruysse, L. & Hanssens, M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 27, 939–958 (2006).
Wallukat, G., Neichel, D., Nissen, E., Homuth, V. & Luft, F.C. Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia. Can. J. Physiol. Pharmacol. 81, 79–83 (2002).
Walther, T. et al. Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension 46, 1275–1279 (2005).
Takimoto, E. et al. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 274, 995–998 (1996).
Acknowledgements
We thank Merck for the gift of losartan. This work was supported by US National Institutes of Health grants HL076558 (to Y.X.) and HD34130, March of Dimes grant 6-FY06-323 and the Texas Higher Education Coordinating Board (to R.E.K.).
Author information
Authors and Affiliations
Contributions
C.C.Z. performed total IgG purification; blood pressure, urinary protein, sFlt1 and sEng measurements in antibody-injected pregnant mice; fetal kidney and placenta isolation and cell culture bioassays for AT1-AA biological activity; and contributed to writing, editing and generation of figures. Y.Z. carried out antibody injections, affinity purification and characterization of AT1-AAs, western blot experiments and ELISA for human IgG; and contributed to writing and generation of figures. R.A.I. procured human subjects' approvals, maintained the database of de-identified human subject information, measured blood pressure and urinary protein in antibody-injected nonpregnant mice, performed kidney and placental histology and contributed to writing and generation of figures. H.Z. provided expertise in kidney and placental histology and contributed to writing and editing of histological studies in both placenta and kidney. T.M. injected mice with antibody and helped with blood pressure and other measurements. E.J.P. provided expertise regarding the electron microscopic analysis of kidney. M.J.H. provided expertise in placental histology. S.M.R. provided expertise in pre-eclampsia, collected human subject samples amd analyzed human subject data. R.E.K. provided expertise in pre-eclampsia and the renin angiotensin system and contributed to the writing and editing of the manuscript. Y.X. was the principal investigator of the study, oversaw the overall design of experiments and interpretation of all results, organized the manuscript including text and figures, and did the final editing of the manuscript.
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Figs. 1-2 and Supplementary Tables 1-2 (PDF 365 kb)
Rights and permissions
About this article
Cite this article
Zhou, C., Zhang, Y., Irani, R. et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med 14, 855–862 (2008). https://doi.org/10.1038/nm.1856
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.1856
This article is cited by
-
The role of immune cells and mediators in preeclampsia
Nature Reviews Nephrology (2023)
-
Renin-angiotensin system in the placenta of women with preeclampsia
Hypertension Research (2023)
-
Primary aldosteronism in pregnancy
Reviews in Endocrine and Metabolic Disorders (2023)
-
The Clinical Value of Rodent Models in Understanding Preeclampsia Development and Progression
Current Hypertension Reports (2023)
-
Biochemical markers in the pathogenesis of preeclampsia: novel link between placental growth factor and interleukin-6
Molecular and Cellular Biochemistry (2022)